|
US2003113271A1
|
|
Formulations for pulmonary delivery
|
|
EP1414633A1
|
|
Devices and methods for the production of particles
|
|
AU1169002A
|
|
Altered hox and wnt7a expression in human lung cancer
|
|
AU7157901A
|
|
Progesterone receptor-regulated gene expression and methods related thereto
|
|
AU6687801A
|
|
Methods and apparatus for increasing resolution in digital imaging systems by offsetting pixels
|
|
US2002132007A1
|
|
Sustainded-release composition including amorphous polymer
|
|
AU5113201A
|
|
Compositions and methods for regulating metabolism in plants
|
|
WO0176650A1
|
|
Compositions and methods for promoting wound healing
|
|
EP1225916A1
|
|
Compositions and methods for controlled-release delivery and increased potency of pharmaceuticals via hydrophobic ion-pairing
|
|
AU1082901A
|
|
Method for modulation of cell phenotype
|
|
US6417950B1
|
|
Three-color imaging on each pixel for increased resolution
|
|
US6479007B1
|
|
Apparatus and method for controlling pore size in polymeric membranes and thin films
|
|
US6565820B1
|
|
Low temperature oxidation using support molten salt catalysts
|
|
US6228843B1
|
|
Method of using PKC inhibiting compounds to treat vascular disease
|
|
US6319521B1
|
|
Microparticles of lactide-co-glycolide copolymers and methods of making and using the same
|
|
US6403672B1
|
|
Preparation and use of photopolymerized microparticles
|
|
WO0021552A1
|
|
Glycoprotein antigens, antibodies specific thereto and method for producing same
|
|
NZ511043A
|
|
Semiconductor laser based sensing device
|
|
US6377341B1
|
|
Refractive index based detector system for liquid chromatography
|
|
WO0004987A1
|
|
Method and apparatus for determining the state of fouling/cleaning of membrane modules
|
